AGN-199201 for the Treatment of Erythema With Rosacea
| Status: | Completed |
|---|---|
| Conditions: | Cosmetic, Dermatology |
| Therapuetic Areas: | Dermatology / Plastic Surgery |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 3/30/2013 |
| Start Date: | December 2012 |
| End Date: | November 2013 |
| Contact: | Allergan Inc. |
| Email: | clinicaltrials@allergan.com |
This study will evaluate the safety and efficacy of 3 doses of AGN-199201 once and twice
daily compared to vehicle for the treatment of moderate to severe facial erythema associated
with rosacea.
Inclusion Criteria:
- Redness of the skin caused by rosacea
Exclusion Criteria:
- ≥3 inflammatory lesions
- Laser light-source or other energy based therapy in the last 6 months
- Any prescription or over the counter product for the treatment of acne or rosacea in
the last 14 days
We found this trial at
1
site
Click here to add this to my saved trials
